Method for determining likelihood of an inflammatory gastrointestinal tract disease
AssigneeAqsens Health Oy
InventorsJanne Kulpakko, Anita Jansen, Riikka Erkkilä
Life of this patent
Estimating the term…
Loading patent…
AssigneeAqsens Health Oy
InventorsJanne Kulpakko, Anita Jansen, Riikka Erkkilä
Estimating the term…
The aspects of the disclosed embodiments relate to method for determining a likelihood of an inflammatory gastrointestinal tract disease. The method includes diluting a biological sample of a human subject and contacting it with 8-anilinonaphthalene-1-sulfonic acid as modulating agent and further with a reagent, said reagent comprising a peroxidase enzyme and a label selected from a europium chloride and terbium chloride. The sample is incubated and excited, and the time-resolved luminescence signal of the label in the sample is measured. If the luminescence signal is at least 112% higher than for a control sample from a human so subject without of an inflammatory intestine disease, an increased likelihood of an inflammatory intestine disease of the human subject is determined.
A method for determining likelihood of an inflammatory gastrointestinal tract disease, comprising
Dependencies are inferred from the claim text.